CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...